In Silico Performance vs Real-World Utility of Surgical Prediction Models: What Does it Take to Change a Surgeon's Mind?

被引:0
|
作者
Wang, Joyce E.
Kennedy, Chris J.
Brat, Gabriel A.
Marwaha, Jayson S.
机构
关键词
RISK CALCULATOR;
D O I
10.1097/XCS.0000000000000757
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:583 / 584
页数:2
相关论文
共 9 条
  • [1] What Does It Take to Transform Real-World Data Into Real-World Evidence?
    Ramamoorthy, Anuradha
    Huang, Shiew-Mei
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 10 - 18
  • [2] Improving Clinical Utility of Real-World Prediction Models: Updating Through Recalibration
    Bullock, Garrett S.
    Shanley, Ellen
    Thigpen, Charles A.
    Arden, Nigel K.
    Noonan, Thomas K.
    Kissenberth, Michael J.
    Wyland, Douglas J.
    Collins, Gary S.
    [J]. JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 2023, 37 (05) : 1057 - 1063
  • [3] Does clinically measured walking capacity contribute to real-world walking performance in Parkinson's disease?
    Zajac, Jenna A.
    Cavanaugh, James T.
    Baker, Teresa
    Duncan, Ryan P.
    Fulford, Daniel
    Girnis, Jaimie
    LaValley, Michael
    Nordahl, Timothy
    Porciuncula, Franchino
    Rawson, Kerri S.
    Saint -Hilaire, Marie
    Thomas, Cathi A.
    Earhart, Gammon M.
    Ellis, Terry D.
    [J]. PARKINSONISM & RELATED DISORDERS, 2022, 105 : 123 - 127
  • [4] Multi-parameter prediction of driver's lane change behavior based on real-world driving tests
    Ma, Yong
    Fu, Rui
    Guo, Ying-Shi
    Yuan, Wei
    Wu, Hai-Bo
    [J]. Ma, Yong, 1600, Editorial Department of Journal of Chang'an University (Natural Science Edition) (34): : 101 - 108
  • [5] PREDICTIVE PERFORMANCE OF DIFFERENT POPULATION PHARMACOKINETIC MODELS IN A REAL-WORLD COHORT OF CROHN'S DISEASE PATIENTS
    Samuels, Abigail
    Punt, Nieko
    Reifenberg, Jack
    Mizuno, Tomoyuki
    Colman, Ruben
    Menke, Frank
    Vogt, Aaron
    Vinks, Alexander
    Minar, Phillip
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 : S99 - S100
  • [6] PREDICTIVE PERFORMANCE OF DIFFERENT POPULATION PHARMACOKINETIC MODELS IN A REAL-WORLD COHORT OF CROHN'S DISEASE PATIENTS
    Samuels, Abigail
    Punt, Nieko
    Reifenberg, Jack
    Mizuno, Tomoyuki
    Colman, Ruben
    Menke, Frank
    Vogt, Aaron
    Vinks, Alexander
    Minar, Phillip
    [J]. GASTROENTEROLOGY, 2022, 162 (03) : S99 - S100
  • [7] What Does It Take to Change an Editor's Mind? Identifying Minimally Important Difference Thresholds for Peer Reviewer Rating Scores of Scientific Articles
    Callaham, Michael
    John, Leslie K.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2018, 72 (03) : 314 - 318
  • [8] What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?
    Lefebvre, T.
    Cormons, R.
    Faucheron, J. -L.
    Baudrant, M.
    Bonaz, B.
    Mathieu, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S361 - S362
  • [9] Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models
    Seyednasrollah, Fatemeh
    Mahmoudian, Mehrad
    Rautakorpi, Liisa
    Hirvonen, Outi
    Laitinen, Tarja
    Jyrkkio, Sirkku
    Elo, Laura L.
    [J]. EUROPEAN UROLOGY, 2017, 72 (03) : E70 - E71